Breaking News
September 26, 2018 - Epidural stimulation and locomotor training helps patients with spinal cord injury to walk
September 26, 2018 - RTI’s TETRAfuse 3D Technology wins 2018 Spine Technology Award
September 26, 2018 - Researchers discover novel targeting agents to prevent cancer metastasis
September 26, 2018 - Researchers develop molecule that makes cancer cells sensitive to radiotherapy
September 26, 2018 - American Cancer Society releases new cookbook for cancer patients
September 26, 2018 - Relmada Therapeutics Provides Enrollment Update in Phase 2 Study of REL-1017 (dextromethadone) in Patients with Major Depressive Disorder
September 26, 2018 - Many doctors in India miss TB signs: study
September 26, 2018 - Horwitz Prize Awarded for Work on Hormones
September 26, 2018 - Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’
September 26, 2018 - Most running injuries may be influenced by simple technique errors, finds study
September 26, 2018 - Optimizing dopaminergic treatment improves non-motor symptoms and quality of life
September 26, 2018 - NIRS-IVUS imaging identifies patients and plaques vulnerable to subsequent adverse cardiac events
September 26, 2018 - New insights into what drives organ transplant rejection
September 26, 2018 - Tiny Device Is a ‘Huge Advance’ for Treatment of Severe Heart Failure
September 26, 2018 - Research shows possibility to postpone cumbersome treatment for low-risk MDS patients
September 26, 2018 - CSU chemists may help in making extracorporeal life support devices more effective
September 26, 2018 - Brain marker linked with aggression in toddlers identified
September 26, 2018 - Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer’s disease
September 26, 2018 - PCORI, AHRQ announce awards to support patient-centered outcomes research in learning health systems
September 26, 2018 - Scientists discover and characterize human skeletal stem cells
September 26, 2018 - Repeat CT Common in Peds Traumatic Epidural Hematoma
September 26, 2018 - Genetics Home Reference: bunion
September 26, 2018 - Increase observed in hearts from drug-intoxicated donors
September 26, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 26, 2018 - TINY cancer detection device shows promise as point-of-care detector of KSHV
September 26, 2018 - Women with non-small cell lung cancers live longer than their male counterparts
September 26, 2018 - KTU researchers engineer experimental bone to help treat osteoarthritis patients
September 26, 2018 - Foundation for a Smoke-Free World calls for proposals to implement Smoke-Free Index
September 26, 2018 - Functional Imagery Training helps lose five times more weight than talking therapy
September 26, 2018 - Fewer American Teens Having Sex, Most Using Birth Control
September 26, 2018 - We are predisposed to forgive, new research suggests
September 26, 2018 - Insomnia Exacts Heavy Toll on Quality of Life
September 26, 2018 - Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility
September 26, 2018 - Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s
September 26, 2018 - Study finds persistent rate of lawnmower injury-related emergency department visits
September 26, 2018 - Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson’s disease
September 26, 2018 - Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award
September 26, 2018 - New spinout company to tackle drug-resistant infections with novel antibiotics
September 26, 2018 - In depression the brain region for stress control is larger
September 26, 2018 - Smuggling RNA into cells can activate the immune system to fight cancer
September 26, 2018 - Special Focus Issue takes wide view of complementary and integrative medicine in cancer
September 26, 2018 - Researchers now confirm that genome duplication drives evolution of species
September 25, 2018 - Study provides evidence of beta lactamase producing, antimicrobial resistant E. coli in U.S. retail meat
September 25, 2018 - UCI study finds new cause of cerebral microbleeds
September 25, 2018 - Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders
September 25, 2018 - Chinese and German researchers to cooperate more closely in future for better food
September 25, 2018 - Recent study helps predict probability of pregnant mothers to have child with autism
September 25, 2018 - New online, sound matching tool offers tinnitus sufferers potential treatment options
September 25, 2018 - UC Davis researchers take critical step in developing more effective Salmonella vaccine
September 25, 2018 - Antibiotics best paediatric treatment for children’s chronic wet cough
September 25, 2018 - Looking beyond opioids: Stanford pain psychologist briefs Congress
September 25, 2018 - Organs actively fighting back against autoimmune diseases, finds study
September 25, 2018 - Lancaster professor aims to understand how genes affect smoking cessation
September 25, 2018 - Human-oriented perspective needed to better understand Parkinson’s disease
September 25, 2018 - Physical activity may have beneficial effects for people with rare Alzheimer’s disease
September 25, 2018 - FDA Updates on Valsartan Recalls
September 25, 2018 - 3-D-printed tracheal splints used in groundbreaking pediatric surgery
September 25, 2018 - Who is the designated driver, or proxy, for your health decisions?
September 25, 2018 - New chemo-optogenetic method enables multi-directional activity control of cellular processes
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Patients with paralysis manage to walk thanks to new technology
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - New model enables anyone to run powerful simulations, complex calculations easily
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - Study analyzes quality of protein supplements in function of source, treatment and storage
September 25, 2018 - FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
AHA Addresses Heart Effects of Breast Cancer Tx

AHA Addresses Heart Effects of Breast Cancer Tx

image_pdfDownload PDFimage_print

Breast cancer patients and survivors may have a heightened risk of cardiovascular disease (CVD) and require careful monitoring, particularly when treatment includes drugs that can damage the heart, according to a scientific statement from the American Heart Association (AHA).

Breast cancer patients, particularly older patients, are more likely to die of CVD than breast cancer, and patients may benefit from management strategies that weigh the cancer benefits versus heart risks, authors of the statement wrote in Circulation.

“Any patient who is going to undergo breast cancer treatment, whether they have heart disease at the beginning or not, should be aware of the potential effects of the treatment on their heart,” writing group chair Laxmi Mehta, MD, said in a statement. “This should not deter or scare patients from undergoing breast cancer treatment but should allow them to make informed decisions with their doctor on the best cancer treatment for them.”

The association between breast cancer and CVD begins with overlapping risk factors, including older age, obesity, and smoking. As much as 80% of attributable risk for CVD can be eliminated by attention to modifiable risk factors, including a healthy diet, abstinence from tobacco, maintenance of a healthy weight, blood pressure control, a favorable lipid profile, diabetes management, and physical activity. Some evidence suggests that following the AHA Life’s Simple 7 lifestyle-based health campaign may help lower the risk of cancer.

The evidence regarding postmenopausal hormone replacement therapy (HRT) is mixed. Data from the Nurses Health Study showed an increased risk of breast cancer in women taking HRT. In contrast, data from the Women’s Health Initiative suggested the effect varied according to the type of hormones used and whether a woman had an intact uterus. Several studies have found positive associations between HRT and CVD in older postmenopausal women and women with existing coronary disease.

Authors of the AHA statement concluded, “These data confirm that postmenopausal HRT is associated with both breast cancer and CVD … and this is a potentially modifiable risk factor for both diseases.”

With regard to potential adverse effects of cancer treatment on the heart, the AHA panel noted that two widely used cancer medications — doxorubicin and trastuzumab (Herceptin) — can damage heart tissue and reduce the heart’s functional capacity, effects associated with the development of heart failure.

The anthracycline class of chemotherapeutic drugs can trigger abnormal heart rhythms, which may be benign or potentially life-threatening. Antimetabolites can cause vasospasm that produces symptoms ranging from chest pain to heart attack.

Among options for hormonal breast cancer therapy, tamoxifen favorably affects lipid profiles, but studies showed no beneficial effect on CVD risk. Tamoxifen adversely affects clotting parameters and increases the risk of venous thrombosis and thromboembolism. Aromatase inhibitors (AI) are associated with a lower risk of clot-related disorders as compared with tamoxifen. Pooled data and meta-analyses suggested that AI use modestly but significantly increases the risk of CVD versus tamoxifen.

“Despite the small absolute risk, the clinical relevance of these findings could be high in specific populations at risk,” the AHA panel concluded.

Radiation therapy can affect blood vessels in ways that make patients more likely to develop coronary artery disease. Despite improvements in technology and delivery techniques, “irradiation to smaller volumes of the heart results in cardiac perfusion defects,” the AHA panel stated.

Certain clinical management strategies may help reduce or prevent the adverse effects of breast cancer therapy. For example, some studies suggested that administration of doxorubicin by slow infusion rather than bolus may minimize damage to the heart. Additionally, the drug dexrazoxane is approved for minimizing heart damage in patients with metastatic breast cancer treated with high doses of doxorubicin.

Heart health should figure into the initial planning of breast cancer treatment, including drug choices and follow-up monitoring during treatment, said Mehta. In some cases, pre-existing heart conditions may guide the course of cancer care, or cancer therapy may adversely affect the heart and necessitate changes in treatment plans.

“Ideal breast cancer outcomes are reliant on coexisting cardiovascular health along the entire journey of breast cancer treatment,” the AHA panel concluded.

Mehta disclosed no relevant relationships with industry. One or more coauthors disclosed relationships with Boehringer INgelheim, Amarin, Amgen, Genentech, AstraZeneca, Lilly, NovoNordisk, Pharmacosmos, Sunovion, and Hoffman La Roche

2018-01-02T00:00:00-0500

last updated

Tagged with:

About author

Related Articles